Krishna Vaddi, CEO at Prelude Therapeutics Inc (PRLD), bought 39,105 shares at $0.75 ($29K) on 2025-03-17, disclosed to the SEC on 2025-03-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.75 | 29,999 | $22K | 76.7% |
| 2 | $0.75 | 9,106 | $7K | 23.3% |
| Total | $0.75 avg | 39,105 | $29K | 100% |
| Filing → |
| PRLD | BUY | 2025-03-14 | $70K | — | Filing → |
| PRLD | BUY | 2025-01-03 | $6K | — | Filing → |
| PRLD | BUY | 2025-01-02 | $12K | — | Filing → |